These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 22086678

  • 1. Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing.
    Bartley AN, Luthra R, Saraiya DS, Urbauer DL, Broaddus RR.
    Cancer Prev Res (Phila); 2012 Feb; 5(2):320-7. PubMed ID: 22086678
    [Abstract] [Full Text] [Related]

  • 2. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ, Ramirez N, Pritchard CC, Hampel H, Chassen AS, Simmons LV, Schmidt AP, Gao F, Brinton LA, Backes F, Landrum LM, Geller MA, DiSilvestro PA, Pearl ML, Lele SB, Powell MA, Zaino RJ, Mutch D.
    J Clin Oncol; 2015 Dec 20; 33(36):4301-8. PubMed ID: 26552419
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
    Dudley B, Brand RE, Thull D, Bahary N, Nikiforova MN, Pai RK.
    Am J Surg Pathol; 2015 Aug 20; 39(8):1114-20. PubMed ID: 25871621
    [Abstract] [Full Text] [Related]

  • 5. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
    Berginc G, Bracko M, Ravnik-Glavac M, Glavac D.
    Fam Cancer; 2009 Aug 20; 8(4):421-9. PubMed ID: 19526325
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
    Zighelboim I, Powell MA, Babb SA, Whelan AJ, Schmidt AP, Clendenning M, Senter L, Thibodeau SN, de la Chapelle A, Goodfellow PJ.
    Fam Cancer; 2009 Aug 20; 8(4):501-4. PubMed ID: 19672700
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
    Mueller J, Gazzoli I, Bandipalliam P, Garber JE, Syngal S, Kolodner RD.
    Cancer Res; 2009 Sep 01; 69(17):7053-61. PubMed ID: 19690142
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability.
    Amira AT, Mouna T, Ahlem B, Raoudha A, Majid BH, Amel H, Rachida Z, Nadia K.
    Tumour Biol; 2014 Jul 01; 35(7):6283-91. PubMed ID: 24643686
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A.
    J Clin Oncol; 2008 Dec 10; 26(35):5783-8. PubMed ID: 18809606
    [Abstract] [Full Text] [Related]

  • 12. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.
    Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT.
    Am J Surg Pathol; 2012 Feb 10; 36(2):163-72. PubMed ID: 22189970
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
    McConechy MK, Talhouk A, Li-Chang HH, Leung S, Huntsman DG, Gilks CB, McAlpine JN.
    Gynecol Oncol; 2015 May 10; 137(2):306-10. PubMed ID: 25636458
    [Abstract] [Full Text] [Related]

  • 17. [Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].
    Olagui GS, Pignot G, Rouquette A, Vieillefond A, Amsellem-Ouazana D, de Longchamps NB, Radenen B, Zerbib M, Terris B.
    Bull Cancer; 2014 Feb 10; 101(2):144-50. PubMed ID: 24556207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.
    Hampel H.
    J Natl Compr Canc Netw; 2010 May 10; 8(5):597-601. PubMed ID: 20495086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.